A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
Clinical trial NCT07140393 · RECRUITING
Trial details
- NCT number
- NCT07140393
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2027-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.